Literature DB >> 23061305

Prevalence of osteoporosis and osteopenia in Thai COPD patients.

Nuttapol Rittayamai1, Benjamas Chuaychoo, Apiradee Sriwijitkamol.   

Abstract

OBJECTIVE: To study the prevalence of osteoporosis and osteopenia in Thai COPD patients and the factors associated with osteoporosis. MATERIAL AND
METHOD: A cross sectional study was used to evaluate 102 male stable COPD patients. Bone mineral density at lumbar spine (L2-4) and femoral neck were measured by dual energy x-ray absorptiometer scan. Demographic data including age, body mass index (BMI), inhaled corticosteroids use, tobacco smoke, force expiratory volume at 1 second (FEV1), and high sensitivity C-reactive protein (hs-CRP) were analyzed.
RESULTS: The overall prevalence of osteoporosis and osteopenia according to the lowest T-score at either L2-4 or femoral neck were 31.4% and 32.4%, respectively. This prevalence of osteoporosis in COPD patients was higher than that in age-matched Thai males from historical data (31.4% vs. 12.6%, respectively). BMI and hs-CRP were significantly associated with osteoporosis. There was no association between osteoporosis and severity of COPD, age, smoking, and corticosteroid use. The predictive value of BMI < 20.5 kg/m2 and hs-CRP > 2.3 mg/L demonstrated risk of osteoporosis in COPD patients (adjusted Odds ratio 7.2 and 4.1, respectively).
CONCLUSION: The prevalence of osteoporosis and osteopenia in Thai COPD patients was higher than that in normal age-matched Thai males. Osteoporosis was associated with low BMl and high level of hs-CRP when compared to COPD patients with normal bone mineral density.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061305

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  7 in total

Review 1.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 2.  Musculoskeletal disorders in chronic obstructive pulmonary disease.

Authors:  Nele Cielen; Karen Maes; Ghislaine Gayan-Ramirez
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

3.  Vitamin D should be supplemented more actively in elderly patients with coronary heart disease combined with COPD.

Authors:  Ling Zhang; Qiao-Ying Yuan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-21

4.  Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.

Authors:  Chun-Wei Lin; Yih-Yuan Chen; Yi-Jen Chen; Chi-Yen Liang; Ming-Shian Lin; Wei Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-29

5.  Effects of teriparatide on lung function and pain relief in women with multiple osteoporotic vertebral compression fractures.

Authors:  Chien-Min Chen; Ping-Yi Lin; Ying-Chieh Chen; Yong Jin; Abel Po-Hao Huang; Sheng-Hao Lin; Ming-Tai Hsing; Yen-Po Cheng; Chun-Yuan Cheng; Chung-Tien Lin
Journal:  Surg Neurol Int       Date:  2014-08-28

6.  Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan.

Authors:  Chu-Hsu Lin; Kai-Hua Chen; Chien-Min Chen; Chia-Hao Chang; Tung-Jung Huang; Chia-Hung Lin
Journal:  PeerJ       Date:  2018-01-12       Impact factor: 2.984

Review 7.  Progress in the mechanism and targeted drug therapy for COPD.

Authors:  Cuixue Wang; Jiedong Zhou; Jinquan Wang; Shujing Li; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Signal Transduct Target Ther       Date:  2020-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.